NIT
WST icon

NumerixS Investment Technologies’s West Pharmaceutical WST Stock Holding History

NumerixS Investment Technologies’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,700
Closed -$350K – 1381
2017
Q2 		$350K Buy
3,700
+1,100
+42% +$101K 0.05% 437
2017
Q1 		$212K Buy
+2,600
New +$217K 0.02% 698

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

NumerixS Investment Technologies's WST Position: Q3 2017 in Review

NumerixS Investment Technologies sold out of West Pharmaceutical (WST) in Q3 2017, closing a stake of 3,700 shares — an estimated $350K sold.

NumerixS Investment Technologies first reported a position in WST in Q1 2017 and held it in 2 quarters. The position peaked at $350K in Q2 2017. 302 funds tracked by Wall St. Rank hold WST as of Q3 2017.

  • NumerixS Investment Technologies reported no remaining West Pharmaceutical position as of Q3 2017 after selling out during the quarter.
  • NumerixS Investment Technologies sold 3,700 West Pharmaceutical shares in Q3 2017, an estimated $350K.
  • NumerixS Investment Technologies first reported a position in West Pharmaceutical in Q1 2017 and held it in 2 quarters.
  • NumerixS Investment Technologies's West Pharmaceutical position peaked at $350K in Q2 2017.
  • 302 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2017.

Based on NumerixS Investment Technologies's 13F filing for Q3 2017, filed 13 Nov 2017.